Table 3.
Safety profile and oncologic outcomes.
| N = 328 | Percentage % | SG | CG | Percentage % | ||
|---|---|---|---|---|---|---|
| Early Complications | No | 285 | 86.9% | 163 | 122 | 57.2% (SG) - 42.8% (CG) |
| Yes | 43 | 13.1% | 29 | 14 | 67.4% (SG) - 32.6% (CG) | |
| Wound Dehiscence | 8 | 2.4% | 5 | 3 | 62.5% (SG) - 37.5% (CG) | |
| Hematoma | 3 | 0.9% | 1 | 2 | 33.3% (SG) - 66.7% (CG) | |
| Infection | 24 | 7.3% | 8 | 16 | 33.3% (SG) - 66.7% (CG) | |
| Skin-nipple necrosis | 8 | 2.4% | 5 | 3 | 62.5% (SG) - 37.5% (CG) | |
| Implant Removal | No | 313 | 95.4 | 185 | 128 | 59.1% (SG) - 40.9% (CG) |
| Yes | 15 | 4.6 | 7 | 8 | 46.7% (SG) - 53.3% (CG) | |
| Symmetrisation | Immediate | 14 | 4.3% | 8 | 6 | 57.1% (SG) - 42.9% (CG) |
| Delayed | 36 | 11.0% | 18 | 18 | 50.0% (SG) - 50.0% (CG) | |
| No | 174 | 53.0% | 99 | 75 | 56.9% (SG) - 43.1% (CG) | |
| Bilateral Mastectomy | 104 | 31.7% | 42 | 62 | 40.4% (SG) - 59.6% (CG) | |
| Second Look | Fat Grafting (1) | 53 | 16.2% | 33 | 20 | 62.3% (SG) - 37.7% (CG) |
| Fat Grafting (2) | 7 | 2.1% | 1 | 6 | 14.3% (SG) - 85.7% (CG) | |
| Fat Grafting (3) | 1 | 0.3% | 0 | 1 | 0% (SG) - 100% (CG) | |
| Implant Exchange | 1 | 0.3% | 0 | 1 | 0% (SG) - 100% (CG) | |
| Implant Exchange + Fat Grafting | 3 | 0.9% | 1 | 2 | 33.3% (SG) - 66.7% (CG) | |
| No Fat Grafting | 257 | 78.4% | 134 | 123 | 52.1% (SG) - 47.9% (CG) | |
| NAC Reconstruction + Fat Grafting | 6 | 1.8% | 2 | 4 | 33.3% (SG) - 66.7% (CG) | |
| Capsular contracture | Grade IV | 9 | 2.7% | 1 | 8 | 11.1% (SG) - 88.9% (CG) |
| Grade III | 32 | 9.7% | 4 | 28 | 12.5% (SG) - 87.5% (CG) | |
| Grade II | 33 | 10% | 10 | 23 | 30.3% (SG) - 69.7% (CG) | |
| Grade I | 254 | 77.4% | 110 | 144 | 43.3% (SG) - 56.7% (CG) |